Lenalidomide Capsules IP are anticancer medicines used in the treatment of certain blood cancers by regulating abnormal immune and cancer-cell activity.
Key Benefits
- Supports treatment of multiple myeloma
- Used in selected myelodysplastic syndromes
- Helps inhibit the growth and survival of abnormal blood cells
- Modulates immune system activity against cancer cells
- May help support treatment response when used in appropriate combination therapies
How It Works
Lenalidomide has immunomodulatory and anticancer effects. It influences immune-cell activity, affects inflammatory signaling, and can interfere with the growth and survival of certain abnormal blood cells. Its specific role and combination with other medicines depend on the type and stage of cancer.
Common Side Effects
- Fatigue
- Nausea
- Diarrhea or constipation
- Headache
- Skin rash
- Muscle or joint pain
- Low blood cell counts
- Increased risk of infections
Important Information
Lenalidomide Capsules IP must be used strictly under the supervision of a qualified oncologist. It can cause serious birth defects and must not be used during pregnancy; appropriate pregnancy-prevention and testing requirements apply to eligible patients. It may also increase the risk of blood clots and can cause low blood counts, so regular blood monitoring is important. Inform your healthcare professional about other medicines, particularly anticoagulants or medicines that may increase clotting or bleeding risk. Do not donate blood or sperm during treatment and for the required period after treatment as advised by the treating specialist.